Tamarac, FL -- (SBWIRE) -- 10/09/2013 -- Pelvic-Mesh.net (PM), a transvaginal mesh attorney and advocate network, is pleased and encouraged by the recent Bloomberg report which revealed that C.R. Bard, Endo Health Solutions, American Medical Systems, Boston Scientific, Coloplast and Cook Medical ?have all taken initiative and begun to discuss the feasability of settling their defective mesh patch suits en masse. One notable absense is Johnson & Johnson, currently facing lawsuits over mesh products made by its Ethicon Inc division.
According to Bloomberg?s sources, Plaintiffs? Attorneys want U.S. District Judge Joseph Goodwin in Charleston, West Virginia, who is overseeing the multidistrict litigations (MDLs) ? composed of more than 30,000 separate lawsuits against the mesh makers ? to appoint a settlement committee. The total number could rise to encompass more than 50,000 lawsuits, the sources told Bloomberg.
It is too early in the process to believe that these cases are on a settlement track. But whether it ends up in settlement or trial, our goal has been and always will be getting fair and sufficient settlements for our clients as compensation for not only their injuries, but the negligence of the manufacturers involved.
This recent development follows the settlements of two earlier pelvic mesh lawsuit trials by C.R. Bard. Most recently, the company settled Virgil v. C.R. Bard Inc., Case No. ATL-L6917-10, which was filed in the Superior Court of New Jersey Law Division, Atlantic County. It was settled prior to Sept. 26, its scheduled start date, according to court documents. The first case C.R. Bard settled happened on the first day of the trial, Aug. 21, in the U.S. District Court for the Southern District of West Virginia, Charleston Division (Queen v. C.R. Bard Inc., Case No. 2:11-cv-00012). In both instances, the settlement amount was not disclosed.
In addition, there are still a total of six MDLs pending in U.S. District Court for the Southern District of West Virginia.
The U.S. Food and Drug Administration (FDA) reported on July 13, 2011, that the most common complications associated with transvaginal mesh may include mesh erosion through the vagina (also called exposure, extrusion, or protrusion), pain, infection, bleeding, pain during sexual intercourse (dyspareunia), organ perforation, urinary problems and other complications.
The FDA has also stated that complications linked to transvaginal mesh implants are ?not rare? and warned that use of such devices may actually be more harmful compared to alternative methods for treating pelvic organ prolapse (POP).
As usual, we continue to offer free case reviews to victims of transvaginal mesh injuries. If you or a loved one underwent a mesh-related surgery for POP or stress urinary incontinence (SUI) and experienced any complications major or minor as a result of the mesh procedure, please visit our website at http://pelvic-mesh.net today.
Copyright © 2005-2013 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)